/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Mustang Bio, Inc. ( Mustang, we, us, our or the Company ) is a clinical-stage biopharmaceutical company focused on translating today s medical breakthroughs into potential cures for difficult-to-treat cancers. We aim to acquire rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development and eventually either …
$0.54
+$0.05 (+10.14%)
EOD Sep 18, 2026
Negative free cash flow of -$5M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$3M
▲ +87.8% YoY
Op. Margin
—
ROIC
-31.40%
▲ +696.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$5M
▲ +53.9% YoY
Op. Cash Flow (TTM)
-$5M
▲ +53.9% YoY
Net Debt
-$15M
Net Cash Position
Cash & Equiv.
$15M
Continue Research
SourceComputed from the 10-Q filed 5 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 6 Aug 2026. How this is calculated.
Price from market data, last close as of 18 Sept 2026. Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.